TRIER PHARM ApS: Financial statements 2022
CVR: 31611083
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
TRIER PHARM ApS (CVR 31611083) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK 61,044 and a net result of DKK 35,907 compared with DKK 9,192 the year before. That is an increase of 91.5% compared with the year before. Equity in the 2022 report amounted to DKK -430,624.
- Gross Profit
- DKK 61,044
- Profit/Loss
- DKK 35,907
- Equity
- DKK -430,624
- Total Assets
- DKK 259,370
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | 61 t. | 36 t. | -431 t. | - |
| 2021 | - | 32 t. | 9 t. | -467 t. | - |
| 2020 | - | -35 t. | -56 t. | -476 t. | - |
| 2019 | 528 t. | -24 t. | -40 t. | -420 t. | - |
| 2018 | 470 t. | -3 t. | -21 t. | -380 t. | - |
Official annual report
Keep an eye on TRIER PHARM ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
TRIER PHARM ApS has published its annual report for 2021. Gross profit came to DKK 31,869, and the net result was DKK 9,192.
About TRIER PHARM ApS
TRIER PHARM ApS is a Danish company of the type Anpartsselskab based in Hellerup, founded in 2008. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Klaus Trier. The company is owned by KLAUS TRIER HOLDING ApS. According to the 2025 annual report, the company had an average of 1 employee. In 2025, the company reported a gross profit of DKK -37,612 and a net result of DKK -67,143 compared with DKK -18,582 the year before. Equity in the 2025 report amounted to DKK -632,769.